Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0700

+0.3%

3:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	2/15/2013 8:02:32 AM
	1 Recommendation Read Replies (1) of 13111

Provectus News Novel use of Rose Bengal (PV-10) in two cases of refractory scalp sarcoma Friday February 15, 2013 In a letter to the editors entitled "Novel use of Rose Bengal (PV-10) in two cases of refractory scalp sarcoma" appearing in Volume 83, Issue 1-2 of ANZ Journal of Surgery, Clara Y. Tam, MBBS, and Susan J. Neuhaus, MBBS, PhD, FRACS of the Department of Surgery, Royal Adelaide Hospital and University of Adelaide report excellent results from the use of PV-10 in treating two patients with refractory scalp sarcoma. The article may be viewed at www.pvct.com/publications/ANZ_Journal-2013-01.html.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next